Combined Subcutaneous, Sublingual Immunotherapy More Effective Than Either Approach Alone for Cross-Reactive Food Allergy: Presented at EAACI

WARSAW, Poland -- June 10, 2009 -- In a study presented at the 28th Congress of the European Academy of Allergy and Clinical Immunology (EAACI), combined subcutaneous and sublingual immunotherapy was more effective in patients with seasonal allergic rhinitis and cross-reactive food allergy than either approach alone. A study investigated the clinical and immune changes in reaction to subcutaneous allergen-specific immunotherapy (SCIT), sublingual allergen-specific immunotherapy (SLIT), and a combination of both treatments in patients with seasonal allergic rhinitis, who also have cross-reactive food allergy, typically displaying clinically as oral allergy syndrome in the majority of patients. The rationale for the study was the assumed increase of the immunomodulatory impact by combining SCIT and SLIT.

http://www.docguide.com/news/content.nsf/news/852571020057CCF6852575D100577458